After the commissioning of new oral anticoagulants for the treatment and prevention of thrombosis, these medications are now widely used within clinical settings. Increasing numbers of patients present to the health services on anticoagulant medications, and it is therefore imperative for surgeons to be aware of the new therapeutic treatments available and how patients will benefit from such interventions. This review highlights the most pertinent learning points for surgeons regarding the indications, pharmacokinetics, and perioperative management of these new oral medications, as a quick reference guide.
Journal article
J Vasc Surg
06/2016
63
1653 - 1657
Administration, Oral, Anticoagulants, Blood Coagulation, Blood Coagulation Tests, Drug Monitoring, Drug Substitution, Fibrinolytic Agents, Hemorrhage, Humans, Patient Selection, Risk Assessment, Risk Factors, Stroke, Thrombosis, Treatment Outcome